Back to search
FDAFDA · Food and drugs·Recall number D-0208-2025

Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90.

Published January 29, 2025 · Recall initiated: January 16, 2025

Summary

FDA records drug Class III recall D-0208-2025, published January 29, 2025 and initiated January 16, 2025. Recalling firm: Appco Pharma LLC; Status: Completed; Reported quantity: 1380 bottles; Lot: Lot #: 2402101UR, Exp 02/28/2027. Class III means the product is not likely to cause adverse health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet

What to do

Voluntary: Firm initiated · Letter

Get an email if VENLAFAXINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
VENLAFAXINE
Manufacturer
Appco Pharma LLC
Distributor
Nationwide USA.
UPC
0343598943909
Lot
Lot #: 2402101UR, Exp 02/28/2027
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90. recalled?

Yes. FDA published recall D-0208-2025 on January 29, 2025. Reported hazard: Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: VENLAFAXINE. UPC: 0343598943909.